08:26 AM EST, 11/17/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday that Wegovy and Ozempic will now be available at a limited time price of $199 per month to new self-pay patients between now and March 31.

The introductory offer is only for the first two months of therapy, and applies to the two lowest doses - 0.25 mg and 0.5 mg - of Wegovy or Ozempic, the company said.

Novo Nordisk ( NVO ) further said that it is reducing the standard monthly self-pay price to $349 per month from $499, beginning today.

Shares of the company were down 1.3% in recent Monday premarket activity.